Stocks | | | Earnings season is upon us and U.S. equity markets can provide bountiful trading opportunities for those who put in the “work”. Seasoned traders understand there are four Super Bowls a year for volatility, momentum and liquidity and that is earnings season. The real work entails maintain... Read the Full Story |
|
From Our PartnersOne bold former hedge fund manager just went on camera to expose how Wall Street is failing American investors right now. He's boiled down what's happening in the markets to just two words. And he's urging people to take notice. You're not going to see the details of what he's predicting anywhere in the news, especially not from the big banks on Wall Street. | | Click here to watch. |
|
Stocks | | | The rural farmlands of the agriculture industry are closely tied to Wall Street. With almost 7 billion people in the world to feed, the agricultural industry has become highly advanced over the years, giving investors a great windfall in the form of growing stock values and dividends. Read the Full Story |
|
Stocks | | | Earnings season inevitably provides a plethora of stocks that react with gappers and dumpers. Gappers are stocks that gap up on results and dumpers are stocks that gap down on results. We will review the key gapper patterns that can be traded intraday. It’s important to remember to focus on th... Read the Full Story |
|
From Our PartnersIf you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval. | | See full details here. |
|
Markets | | | You might wonder what the presence or lack of female executives has to do with Wall Street and deciding which stocks to buy. But while the role of gender equality in any given industry might not be part of an investor’s typical process of fundamental analysis, it cannot be ignored that an increasing number of women are closing the gender gap with men to hold CEO positions. Read the Full Story |
|
Markets | | | Trying to forecast stock price targets is a perpetual work in progress. Whether using quantitative valuation models, fundamental research or technical analysis, the goal is always to try to answer a simple question, “Where is the stock price going?” Read the Full Story |
|
From Our PartnersMany traders become obsessed with the big win. But successful trading isn't about hitting home runs, it's about raising your batting average.
Rob Booker has the blueprint for steady, reliable account growth, like $100 a day, every day, even with tiny accounts. Do you want to leverage incredible risk/reward ratios in your favor? | | Then register now for Rob's $100 Challenge. |
|
The Early Bird Stock Of The Day Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. | | View Today's Stock Pick |
|
